Sanofi pursues sale of painkiller after political controversy
2 hours ago — The sale of a controlling 50-percent stake in Opella to CD&R values the maker of France's leading painkiller, Doliprane, at 16 billion euros ($17.4 billion), Sanofi said.
CD&R Nears Sanofi OTC Deal After Signing With Government
14 hours ago — Latest News. Stock Market. Originals. The Morning Brief. Premium News. Economics. Housing. Earnings. Tech. Crypto. Biden Economy. Markets. Stocks: Most Actives. ... Doliprane is the most-used drug ...
Hands off the Doliprane: French outcry over plan to sell popular ...
6 days ago — In French pharmacies, the brand's colourful boxes often line entire shelf walls, and Doliprane comes in many doses – from 100 mg for newborn babies to 1,000 mg for adults – and in tablet ...
France seeks job guarantees from Sanofi over Doliprane painkiller ...
6 days ago — Doliprane, an over-the-counter painkiller, is France's best-selling drug and news that it could be partially sold to a foreign investor has prompted political concerns, in a first test case for ...
Uproar over sale of beloved French painkiller to American company
6 days ago — Politicians and groups from all sides have said the sale of the popular Doliprane drug would be a 'loss of sovereignty'.
Painkiller sale plan to US gives France major headache
6 days ago — In French pharmacies, the brand's colorful boxes often line entire shelf walls, and Doliprane comes in many doses—from 100 mg for newborn babies to 1,000 mg for adults—and in tablet, capsule ...
Sanofi's potential sale of Doliprane: Impact on France's healthcare ...
3 days ago — Doliprane specifically has faced its own tensions. Former Health Minister François Braun has commented on the news by saying he recalled the “difficulties we had with paracetamol shortages two winters ago”, adding that “this is a major issue in terms of France's sovereignty over the production of medicines”.
France's top-selling painkiller may be sold to the U.S. and
6 days ago — It is so ubiquitous that French people call any paracetamol product Doliprane, even when made by a different manufacturer. Sanofi, France’s biggest healthcare company and among the world’s top...
French government stuck in Doliprane dilemma - Le Monde.fr
4 days ago — On Friday, October 11, the pharmaceutical giant announced its intention to sell 50% of Opella, its subsidiary specializing in over-the-counter products including Doliprane, to an American ...
France could block sale of 'best-selling' drug if production ... - RFI
6 days ago — Doliprane is France's best-selling drug, and news that it could be sold, even in part, to a foreign investor prompted reactions from across the political spectrum.
- Some results have been removed